Posted by Michael Wonder on 01 Feb 2025
FDA approves novel non-opioid treatment for moderate to severe acute pain
30 January 2025 - First drug approved in new class of non-pioid pain medicines; agency continues to take steps to support new approaches for pain management.
Today, the US FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first in class non-opioid analgesic, to treat moderate to severe acute pain in adults.
